Nuwellis (NUWE) Revenue Growth (3y) (2016 - 2026)
Nuwellis (NUWE) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 8.05% |
| 10 | Nuwellis | 204,804.59 | -3.72 Mn | 1.50 Mn | -1.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73% |
| Mar 31, 2026 | 9.58% |
| Dec 31, 2025 | 1.20% |
| Sep 30, 2025 | 2.40% |
| Jun 30, 2025 | -7.97% |
| Mar 31, 2025 | -0.38% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 8.50% |
| Jun 30, 2024 | -4.36% |
| Mar 31, 2024 | -1.07% |
| Dec 31, 2023 | 7.67% |
| Sep 30, 2023 | 8.20% |
| Jun 30, 2023 | 3.66% |
| Mar 31, 2023 | 3.86% |
| Dec 31, 2022 | 19.61% |
| Sep 30, 2022 | 18.15% |
| Jun 30, 2022 | 9.69% |
| Mar 31, 2022 | 16.60% |
| Dec 31, 2021 | 3.08% |
| Sep 30, 2021 | 10.78% |